IDT
IDT Australia Limited
🇦🇺 ASX
📦 LOGISTICS
👑 Overview
📈 Performance
💵 Cost
🤓 Advanced
👨👩👧👦 Community
📈
-5.71%
Annual Growth
5 years average annual growth
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
5
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
IDT Australia Ltd. produces, develops and supplies pharmaceutical products. The company is headquartered in Melbourne, Victoria. The firm is engaged in the supply of products and provision of research and development and other technical services within the pharmaceutical and allied industries. Its business includes research and development, active pharmaceutical ingredient (API) and finished dosage form manufacture (FDF), clinical and commercial, project management, chemical services, analytical chemistry, pharmacy services, pharmaceutical development in all dosage forms, clinical packaging and regulatory affairs services. Its Current Good Manufacturing Practice (cGMP) manufacturing facilities produces both API and FDF across the medicinal cannabis manufacturing space. The company also provides a full-scale service for new drug development and scale-up, commercial active drug manufacture as well as a variety of oral and injectable finished drug dose forms. Its analytical laboratories offer medicinal cannabis cGMP testing.
📈 Performance
Price History
-41.18%
1M
1Y
10Y
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
N/A
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$0.10
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in IDT
5
📊 Total Capital Earnings
$1K
🔃 Average investment frequency
52 weeks
💵 Average investment amount
$757
⏰ Last time a customer invested in IDT
80 days
IDT investor breakdown
💵 Income of investors
More than 200k
150k - 200k
100k - 150k
50%
50k - 100k
33%
Less than 50k
17%
👶 Age of investors
18 - 25
20%
26 - 34
20%
35 - 90
60%
🙋 Legal gender of investors
Female
60%
Male
40%
Pearlers who invest in IDT also invest in...
VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.
🙌 Performance (5Yr p.a)
4.35%
📊 Share price
$104.33 AUD
⛳️ DIVERSIFIED
🧱 MATERIALS
💸 FINANCIALS
IDT Australia Ltd. produces, develops and supplies pharmaceutical products. The company is headquartered in Melbourne, Victoria. The firm is engaged in the supply of products and provision of research and development and other technical services within the pharmaceutical and allied industries. Its business includes research and development, active pharmaceutical ingredient (API) and finished dosage form manufacture (FDF), clinical and commercial, project management, chemical services, analytical chemistry, pharmacy services, pharmaceutical development in all dosage forms, clinical packaging and regulatory affairs services. Its Current Good Manufacturing Practice (cGMP) manufacturing facilities can produce both API and FDF positioning it as a facility in the medicinal cannabis manufacturing space. The company also provides a full-scale service for new drug development and scale-up, commercial active drug manufacture as well as a variety of oral and injectable finished drug dose forms. Its analytical laboratories offer medicinal cannabis cGMP testing.
📦 LOGISTICS
VGS.AX was created on 2014-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard MSCI International Shares Index ETF seeks to track the return of the MSCI World ex-Australia Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax.
🙌 Performance (5Yr p.a)
13.23%
📊 Share price
$134.96 AUD
🌏 GLOBAL
🤖 TECHNOLOGY
⛳️ DIVERSIFIED
📈 HIGH PRICE GROWTH
Little Green Pharma Ltd. produces medicinal cannabis products for sale to Australian patients. The company is headquartered in Perth, Western Australia. The company went IPO on 2020-02-20. The firm has two global production sites for the manufacture of its own-branded and white-label ranges of Good Manufacturing Practice (GMP)-grade medicinal cannabis products, being a 21,500 square meters cultivation and 4,000 square meters GMP manufacturing facility capable of producing over 30 tons of medicinal cannabis biomass per annum located in Denmark (EU) and an indoor cultivation and manufacturing facility located in Western Australia capable of producing three tons of medicinal cannabis biomass per annum. The firm focuses on patient access in the global medicinal cannabis market and is actively engaged in promoting education and outreach programs, as well as participating in clinical investigations and research projects to develop new delivery systems.
📊 Share price
$0.13 AUD
📦 LOGISTICS
A200.AX was created on 2018-05-07 by BetaShares. The fund's investment portfolio concentrates primarily on large cap equity. The ETF currently has 6041.2m in AUM and 200 holdings. A200.AX aims to track the performance of an index (before fees and expenses) comprising 200 of the largest companies by market capitalisation listed on the ASX.
🙌 Performance (5Yr p.a)
4.86%
📊 Share price
$140.68 AUD
🇦🇺 AUSTRALIA
💸 FINANCIALS
⛳️ DIVERSIFIED
Want more shares? Try these...
Integral Diagnostics Ltd. engages in the provision of diagnostic imaging services to general practitioners, medical specialists, and allied professionals. The company is headquartered in Melbourne, Victoria and currently employs 2,000 full-time employees. The company went IPO on 2015-10-21. The principal activity of the Company is the provision of diagnostic imaging services. The company operates brands in four Australian States: Lake Imaging in Victoria, the X-Ray Group in VIC/NSW, South Coast Radiology, Peloton Radiology and Imaging Queensland in Queensland and Apex Radiology in Western Australia. The company also operates in New Zealand through the Astra Radiology, SRG Radiology, Horizon Radiology and Trinity MRI brands. Lake Imaging offers a private radiology service to patients throughout Central and Western Victoria. South Coast Radiology provides medical imaging services and patient care to the Gold Coast and Tweed Heads communities. Imaging Queensland is a provider of advanced diagnostic imaging services and radiology education across Queensland. Apex Radiology provides diagnostic imaging services for patients in rural and regional communities.
🙌 Performance (5Yr p.a)
-2.77%
📊 Share price
$2.90 AUD
🕊️ SOCIALLY AWARE
🩺 HEALTH CARE
Indiana Resources Ltd. is a minerals and development exploration company. The company is headquartered in Thebarton, South Australia. The firm's ground position in the Gawler Craton covers 5,713 km2 (square kilometer) located between Tunkillia and Tarcoola. Its South Australia Projects include Lake Labyrinth Shear Zone (LLSZ), Double Dutch Gold Prospect, Earea Dam and Boomerang. The LLSZ projects hold various targets, including the Minos, North Hicks, Ariadne and Partridge Prospects. Earea Dam is a fully granted mining lease and is located adjacent to the Tarcoola-Glendambo Road and the Perth-Adelaide train line approximately 30 kilometers (km) west of Kingoonya. The Boomerang Gold Prospect is situated approximately 14 km southwest (SW) of the Tarcoola Mine. The firm also acts as the manager of the Joint Venture for the Ntaka Hill Nickel Project. The Ntaka Hill Nickel Project is an advanced nickel sulfide project.
🙌 Performance (5Yr p.a)
78.67%
📊 Share price
$0.10 AUD
⛏️ MINING